SEK 0.97
(-1.62%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -229.36 Million SEK | 16.83% |
2022 | -275.77 Million SEK | -18.26% |
2021 | -233.18 Million SEK | -5.9% |
2020 | -220.19 Million SEK | -23.66% |
2019 | -178.06 Million SEK | -38.73% |
2018 | -128.35 Million SEK | -89.09% |
2017 | -67.87 Million SEK | -12.96% |
2016 | -60.09 Million SEK | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -55.97 Million SEK | -3.23% |
2024 Q2 | -65.77 Million SEK | -17.5% |
2023 Q2 | -65.48 Million SEK | -8.08% |
2023 FY | -229.36 Million SEK | 16.83% |
2023 Q1 | -60.58 Million SEK | 11.4% |
2023 Q4 | -54.22 Million SEK | -11.46% |
2023 Q3 | -48.64 Million SEK | 25.71% |
2022 FY | -275.77 Million SEK | -18.26% |
2022 Q4 | -68.38 Million SEK | -14.37% |
2022 Q3 | -59.79 Million SEK | 20.2% |
2022 Q2 | -74.92 Million SEK | -4.0% |
2022 Q1 | -72.04 Million SEK | -41.29% |
2021 Q2 | -67.92 Million SEK | -7.49% |
2021 FY | -233.18 Million SEK | -5.9% |
2021 Q3 | -49.13 Million SEK | 27.67% |
2021 Q4 | -50.98 Million SEK | -3.78% |
2021 Q1 | -63.19 Million SEK | -11.65% |
2020 FY | -220.19 Million SEK | -23.66% |
2020 Q4 | -56.59 Million SEK | -16.33% |
2020 Q2 | -57.44 Million SEK | -2.64% |
2020 Q3 | -48.65 Million SEK | 15.29% |
2020 Q1 | -55.96 Million SEK | 9.74% |
2019 Q2 | -43.95 Million SEK | -21.02% |
2019 FY | -178.06 Million SEK | -38.73% |
2019 Q4 | -62 Million SEK | -76.77% |
2019 Q3 | -35.07 Million SEK | 20.21% |
2019 Q1 | -36.32 Million SEK | 7.86% |
2018 Q2 | -35.67 Million SEK | -48.95% |
2018 Q3 | -29.3 Million SEK | 17.87% |
2018 Q1 | -23.95 Million SEK | -9.6% |
2018 Q4 | -39.41 Million SEK | -34.52% |
2018 FY | -128.35 Million SEK | -89.09% |
2017 FY | -67.87 Million SEK | -12.96% |
2017 Q2 | -16.29 Million SEK | -8.57% |
2017 Q3 | -16 Million SEK | 1.79% |
2017 Q4 | -21.85 Million SEK | -36.54% |
2017 Q1 | -15.01 Million SEK | 0.0% |
2016 FY | -60.09 Million SEK | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
AddLife AB (publ) | 190 Million SEK | 220.719% |
Biotage AB (publ) | 246 Million SEK | 193.238% |
Bonesupport Holding AB (publ) | 245.02 Million SEK | 193.611% |
Doxa AB (publ) | 291.9 Million SEK | 178.577% |
Elekta AB (publ) | 1.3 Billion SEK | 117.616% |
iZafe Group AB (publ) | -32.17 Million SEK | -612.87% |
Ortivus AB (publ) | -18.24 Million SEK | -1157.144% |
Ortivus AB (publ) | -18.24 Million SEK | -1157.144% |
S2Medical AB (publ) | -22.7 Million SEK | -910.091% |
Synsam AB (publ) | 311 Million SEK | 173.751% |